Furthermore, intrinsic tumor resistance mechanisms such as DNA repair enzyme expression (e.g., O [6]-methylguanine-DNA methyltransferase; MGMT) further diminish TMZ effectiveness and underscore the need for alternative therapeutic approaches in an effort to improve glioma prognosis [13]. This evidence concerns the gene MGMT and central nervous system cancer.